At the end of the latest market close, Novavax Inc. (NVAX) was valued at $30.41. In that particular session, Stock kicked-off at the price of $29.815 while reaching the peak value of $29.94 and lowest value recorded on the day was $27.35. The stock current value is $28.43.Recently in News on September 16, 2022, Novavax Nuvaxovid™ COVID-19 Vaccine Receives Expanded Emergency Use Authorization in Taiwan for Use in Adolescents Aged 12 Through 17. Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the Taiwan Food and Drug Administration (TFDA) has granted expanded emergency use authorization (EUA) for Nuvaxovid™ (NVX-CoV2373) COVID-19 vaccine for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in adolescents aged 12 through 17. You can read further details here
Novavax Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $145.20 on 01/03/22, with the lowest value was $27.35 for the same time period, recorded on 09/19/22.
Novavax Inc. (NVAX) full year performance was -88.02%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Novavax Inc. shares are logging -89.09% during the 52-week period from high price, and 0.64% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $28.25 and $260.69.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 4897137 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Novavax Inc. (NVAX) recorded performance in the market was -80.13%, having the revenues showcasing -29.35% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 2.38B, as it employees total of 1541 workers.
Novavax Inc. (NVAX) in the eye of market guru’s
During the last month, 0 analysts gave the Novavax Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 47.98, with a change in the price was noted -21.78. In a similar fashion, Novavax Inc. posted a movement of -43.38% for the period of last 100 days, recording 6,525,322 in trading volumes.
Novavax Inc. (NVAX): Stocks Technical analysis and Trends
Raw Stochastic average of Novavax Inc. in the period of last 50 days is set at 2.25%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 10.23%. In the last 20 days, the company’s Stochastic %K was 23.33% and its Stochastic %D was recorded 26.99%.
If we look into the earlier routines of Novavax Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -80.13%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -64.12%, alongside a downfall of -88.02% for the period of the last 12 months. The shares increased approximately by -13.85% in the 7-day charts and went up by -23.53% in the period of the last 30 days. Common stock shares were lifted by -29.35% during last recorded quarter.